Catalyst
Slingshot members are tracking this event:
Neurocrine Biosciences Announces Additional Valbenazine (NBI-98854) Data to be Presented at the American Psychiatric Association's 2016 Annual Meeting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NBIX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 16, 2016
Occurred Source:
http://www.neurology.org/content/86/16_Supplement/PL02.003
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Valbenazine, Psychiatric Stability, Underlying Schizophrenia, Schizoaffective Disorder, Mood Disorder, Major Depressive Disorder, Bipolar Disorder, Tardive Dyskinesia, Kinect 3
